153 related articles for article (PubMed ID: 9552084)
21. The effects of GH replacement therapy on cardiac morphology and function, exercise capacity and serum lipids in elderly patients with GH deficiency.
Elgzyri T; Castenfors J; Hägg E; Backman C; Thorén M; Bramnert M
Clin Endocrinol (Oxf); 2004 Jul; 61(1):113-22. PubMed ID: 15212653
[TBL] [Abstract][Full Text] [Related]
22. Systemic metabolic effects of combined insulin-like growth factor-I and growth hormone therapy in patients who have sustained acute traumatic brain injury.
Hatton J; Kryscio R; Ryan M; Ott L; Young B
J Neurosurg; 2006 Dec; 105(6):843-52. PubMed ID: 17405254
[TBL] [Abstract][Full Text] [Related]
23. Effects of growth hormone replacement therapy on IGF-related parameters and on the pituitary-gonadal axis in GH-deficient males. A double-blind, placebo-controlled crossover study.
Juul A; Andersson AM; Pedersen SA; Jørgensen JO; Christiansen JS; Groome NP; Skakkebaek NE
Horm Res; 1998; 49(6):269-78. PubMed ID: 9623518
[TBL] [Abstract][Full Text] [Related]
24. Stress-associated weight gain, fibromyalgia symptoms, cardiometabolic markers, and human growth hormone suppression respond to an amino acid supplement blend: Results of a prospective, cohort study.
Pekarovics S; Beres A; Kelly C; Billes SK; Heaton AL
Front Endocrinol (Lausanne); 2023; 14():1053692. PubMed ID: 36998474
[TBL] [Abstract][Full Text] [Related]
25. Insulin-like growth factor-I (somatomedin C) levels in chronic fatigue syndrome and fibromyalgia.
Buchwald D; Umali J; Stene M
J Rheumatol; 1996 Apr; 23(4):739-42. PubMed ID: 8730136
[TBL] [Abstract][Full Text] [Related]
26. Growth hormone replacement therapy improves body composition and increases bone metabolism in elderly patients with pituitary disease.
Fernholm R; Bramnert M; Hägg E; Hilding A; Baylink DJ; Mohan S; Thorén M
J Clin Endocrinol Metab; 2000 Nov; 85(11):4104-12. PubMed ID: 11095440
[TBL] [Abstract][Full Text] [Related]
27. Octreotide as primary therapy for acromegaly.
Newman CB; Melmed S; George A; Torigian D; Duhaney M; Snyder P; Young W; Klibanski A; Molitch ME; Gagel R; Sheeler L; Cook D; Malarkey W; Jackson I; Vance ML; Barkan A; Frohman L; Kleinberg DL
J Clin Endocrinol Metab; 1998 Sep; 83(9):3034-40. PubMed ID: 9745397
[TBL] [Abstract][Full Text] [Related]
28. Recombinant growth hormone (GH) therapy in GH-deficient adults: a long-term controlled study on daily versus thrice weekly injections.
Amato G; Mazziotti G; Di Somma C; Lalli E; De Felice G; Conte M; Rotondi M; Pietrosante M; Lombardi G; Bellastella A; Carella C; Colao A
J Clin Endocrinol Metab; 2000 Oct; 85(10):3720-5. PubMed ID: 11061530
[TBL] [Abstract][Full Text] [Related]
29. Intravenous micronutrient therapy (Myers' Cocktail) for fibromyalgia: a placebo-controlled pilot study.
Ali A; Njike VY; Northrup V; Sabina AB; Williams AL; Liberti LS; Perlman AI; Adelson H; Katz DL
J Altern Complement Med; 2009 Mar; 15(3):247-57. PubMed ID: 19250003
[TBL] [Abstract][Full Text] [Related]
30. Low growth hormone secretion in patients with fibromyalgia--a preliminary report on 10 patients and 10 controls.
Bagge E; Bengtsson BA; Carlsson L; Carlsson J
J Rheumatol; 1998 Jan; 25(1):145-8. PubMed ID: 9458218
[TBL] [Abstract][Full Text] [Related]
31. An international, randomized, double-blind, placebo-controlled, phase III trial of pregabalin monotherapy in treatment of patients with fibromyalgia.
Pauer L; Winkelmann A; Arsenault P; Jespersen A; Whelan L; Atkinson G; Leon T; Zeiher B;
J Rheumatol; 2011 Dec; 38(12):2643-52. PubMed ID: 21965636
[TBL] [Abstract][Full Text] [Related]
32. A controlled study on serum insulin-like growth factor-I and urinary excretion of growth hormone in fibromyalgia.
Jacobsen S; Main K; Danneskiold-Samsøe B; Skakkebaek NE
J Rheumatol; 1995 Jun; 22(6):1138-40. PubMed ID: 7674243
[TBL] [Abstract][Full Text] [Related]
33. Tramadol and acetaminophen combination tablets in the treatment of fibromyalgia pain: a double-blind, randomized, placebo-controlled study.
Bennett RM; Kamin M; Karim R; Rosenthal N
Am J Med; 2003 May; 114(7):537-45. PubMed ID: 12753877
[TBL] [Abstract][Full Text] [Related]
34. [Efficacy and safety of recombinant human growth hormone solution in children with growth hormone deficiency in China: a multicenter trial].
Hou L; Luo XP; Du ML; Ma HM; Gong CX; Li YC; Shen SX; Zhao ZH; Liang L; Dong GP; Yan CY; Du HW
Zhonghua Er Ke Za Zhi; 2009 Jan; 47(1):48-52. PubMed ID: 19573383
[TBL] [Abstract][Full Text] [Related]
35. α1-Antitrypsin in fibromyalgia: results of a randomized, placebo-controlled, double-blind and crossover pilot trial.
Alegre C; Barceló M; Jardí R; Rodríguez-Frias F; Camprubí S
Musculoskeletal Care; 2012 Sep; 10(3):178-83. PubMed ID: 22190533
[TBL] [Abstract][Full Text] [Related]
36. Fibromyalgia treatment with intravenous tropisetron administration.
Stratz T; Färber L; Varga B; Baumgartner C; Haus U; Müller W
Drugs Exp Clin Res; 2001; 27(3):113-8. PubMed ID: 11447769
[TBL] [Abstract][Full Text] [Related]
37. Low-dose naltrexone for the treatment of fibromyalgia: findings of a small, randomized, double-blind, placebo-controlled, counterbalanced, crossover trial assessing daily pain levels.
Younger J; Noor N; McCue R; Mackey S
Arthritis Rheum; 2013 Feb; 65(2):529-38. PubMed ID: 23359310
[TBL] [Abstract][Full Text] [Related]
38. Effects of once-weekly sustained-release growth hormone: a double-blind, placebo-controlled study in adult growth hormone deficiency.
Biller BM; Ji HJ; Ahn H; Savoy C; Siepl EC; Popovic V; Coculescu M; Roemmler J; Gavrila C; Cook DM; Strasburger CJ
J Clin Endocrinol Metab; 2011 Jun; 96(6):1718-26. PubMed ID: 21411551
[TBL] [Abstract][Full Text] [Related]
39. Evaluation of the efficacy and safety of terguride in patients with fibromyalgia syndrome: results of a twelve-week, multicenter, randomized, double-blind, placebo-controlled, parallel-group study.
Distler O; Eich W; Dokoupilova E; Dvorak Z; Fleck M; Gaubitz M; Hechler M; Jansen JP; Krause A; Bendszus M; Pache L; Reiter R; Müller-Ladner U
Arthritis Rheum; 2010 Jan; 62(1):291-300. PubMed ID: 20039417
[TBL] [Abstract][Full Text] [Related]
40. Safety and efficacy of pregabalin in adolescents with fibromyalgia: a randomized, double-blind, placebo-controlled trial and a 6-month open-label extension study.
Arnold LM; Schikler KN; Bateman L; Khan T; Pauer L; Bhadra-Brown P; Clair A; Chew ML; Scavone J;
Pediatr Rheumatol Online J; 2016 Jul; 14(1):46. PubMed ID: 27475753
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
